The course of attention-deficit/hyperactivity disorder through midlife
- PMID: 36484846
- DOI: 10.1007/s00406-022-01531-4
The course of attention-deficit/hyperactivity disorder through midlife
Abstract
The course of ADHD from childhood up to young adulthood has been characterized in several studies. However, little is known about the course of symptoms into middle age and beyond. This study aims to evaluate predictors of ADHD trajectories in midlife based on three assessments. The follow-up sample comprised 323 adults with ADHD, evaluated at baseline and seven and thirteen years later, from the average ages of 34 up to 47 years old. ADHD status at reassessments was used to characterize trajectories. Demographics, ADHD features, comorbidities, and polygenic scores for ADHD and genetically correlated psychiatric disorders were evaluated to predict ADHD trajectories. Study retention rate was 67% at T2 (n = 216) and 62% at T3 (n = 199). Data from patients evaluated three times showed that 68.8% coursed stable, 25.5% unstable, and 5.7% remission trajectory of ADHD. Women, individuals with more severe syndromes, higher frequency of comorbidities at reassessments, and genetic liability to depression present a higher probability of a stable trajectory. Our findings shed light on midlife ADHD trajectories and their gender, genomic and clinical correlates.
Keywords: Adults; Attention-Deficit/Hyperactivity Disorder; Clinical follow-up; PRS; Trajectories.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Trajectories of attention-deficit/hyperactivity disorder dimensions in adults.Acta Psychiatr Scand. 2017 Aug;136(2):210-219. doi: 10.1111/acps.12757. Epub 2017 May 26. Acta Psychiatr Scand. 2017. PMID: 28555716
-
Attention-Deficit/Hyperactivity Disorder Trajectories From Childhood to Young Adulthood: Evidence From a Birth Cohort Supporting a Late-Onset Syndrome.JAMA Psychiatry. 2016 Jul 1;73(7):705-12. doi: 10.1001/jamapsychiatry.2016.0383. JAMA Psychiatry. 2016. PMID: 27192050
-
Persistence and remission of ADHD during adulthood: a 7-year clinical follow-up study.Psychol Med. 2015 Jul;45(10):2045-56. doi: 10.1017/S0033291714003183. Epub 2015 Jan 23. Psychol Med. 2015. PMID: 25612927
-
Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan.Eur Neuropsychopharmacol. 2018 Oct;28(10):1059-1088. doi: 10.1016/j.euroneuro.2018.08.001. Epub 2018 Sep 6. Eur Neuropsychopharmacol. 2018. PMID: 30195575 Free PMC article. Review.
-
Tourette syndrome in a longitudinal perspective. Clinical course of tics and comorbidities, coexisting psychopathologies, phenotypes and predictors.Dan Med J. 2018 Apr;65(4):B5465. Dan Med J. 2018. PMID: 29619935 Review.
Cited by
-
Fluctuating course of attention-deficit/hyperactivity disorder across development: Multifactorial influences.World J Psychiatry. 2025 Aug 19;15(8):107780. doi: 10.5498/wjp.v15.i8.107780. eCollection 2025 Aug 19. World J Psychiatry. 2025. PMID: 40837790 Free PMC article. Review.
-
Attention-deficit/hyperactivity disorder.Nat Rev Dis Primers. 2024 Feb 22;10(1):11. doi: 10.1038/s41572-024-00495-0. Nat Rev Dis Primers. 2024. PMID: 38388701 Review.
-
Lost diagnoses? A multi-year trajectory of patients with childhood ADHD in the criminal justice system in Switzerland.Front Psychiatry. 2024 Jun 6;15:1403618. doi: 10.3389/fpsyt.2024.1403618. eCollection 2024. Front Psychiatry. 2024. PMID: 38903643 Free PMC article.
-
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder.Discov Ment Health. 2023 Jan 5;3(1):2. doi: 10.1007/s44192-022-00030-1. Discov Ment Health. 2023. PMID: 37861876 Free PMC article. Review.
-
ADHD Follow-Up in Adulthood among Subjects Treated for the Disorder in a Child and Adolescent Mental Health Service from 1995 to 2015.Medicina (Kaunas). 2023 Feb 10;59(2):338. doi: 10.3390/medicina59020338. Medicina (Kaunas). 2023. PMID: 36837537 Free PMC article.
References
-
- Thapar A, Cooper M, Rutter M (2017) Neurodevelopmental disorders. Lancet. Psychiatry 4:339–346. https://doi.org/10.1016/S2215-0366(16)30376-5 - DOI - PubMed
-
- Kooij JJS, Buitelaar JK, van den Oord EJ et al (2005) Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med 35:817–827. https://doi.org/10.1017/s003329170400337x - DOI - PubMed
-
- Vitola ES, Bau CHD, Salum GA et al (2017) Exploring DSM-5 ADHD criteria beyond young adulthood: phenomenology, psychometric properties and prevalence in a large three-decade birth cohort. Psychol Med 47:744–754. https://doi.org/10.1017/S0033291716002853 - DOI - PubMed
-
- Caye A, Rocha TB-M, Anselmi L et al (2016) Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiat 73:705–712. https://doi.org/10.1001/jamapsychiatry.2016.0383 - DOI
-
- Breda V, Rohde LA, Menezes AMB et al (2021) The neurodevelopmental nature of attention-deficit hyperactivity disorder in adults. Br J Psychiatry 218:43–50. https://doi.org/10.1192/bjp.2020.200 - DOI - PubMed
MeSH terms
Grants and funding
- 476529/2012-3/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- 466722/2014-1/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- 424041/2016-2/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- 426905/2016-4/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- 431472/2018-1/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Finance Code 001/Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- FIPE-HCPA 160600/Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- PqG-19/2551-0001731-6/Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
- 19/2551-001668-9/Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
LinkOut - more resources
Full Text Sources
Medical